Searched over 200M research papers
10 papers analyzed
These studies suggest that atrioventricular (AV) block can be congenital or acquired, has various predictive factors and outcomes, and may require interventions like pacemaker implantation or specific management strategies.
20 papers analyzed
Atrioventricular (AV) heart block is a condition where the conduction of electrical impulses from the atria to the ventricles is impaired. This can lead to various degrees of heart block, ranging from first-degree (mild) to complete (third-degree) block. Understanding the pathophysiology, clinical implications, and management strategies for AV block is crucial for effective treatment and patient outcomes.
Congenital AV block is typically diagnosed in utero, at birth, or within the first month of life. It is often caused by immune-mediated injury to the conduction system due to the transplacental passage of maternal anti-SSA/Ro-SSB/La antibodies . This condition can occur in structurally normal hearts or in association with congenital heart disease. Genetic factors, including mutations in genes such as SCN5A, have also been implicated in the pathogenesis of inherited progressive cardiac conduction disorders.
Acquired AV block can result from various etiologies, including ischemic heart disease, cardiomyopathies, and the use of certain medications. For instance, catheter ablation for ventricular arrhythmias can induce AV block, particularly in patients with nonischemic cardiomyopathy or those undergoing transcoronary ethanol ablation. Additionally, first-degree AV block, characterized by a prolonged PR interval, can progress to higher degrees of block, especially in patients with marked prolongation of the PR interval.
The clinical course of congenital AV block can vary. Some patients may remain asymptomatic, while others may develop symptoms such as bradycardia, heart failure, or dilated cardiomyopathy. Early diagnosis and management are critical to prevent sudden death and other complications .
Paroxysmal AV block is characterized by sudden, intermittent episodes of complete heart block, often leading to syncope. This form of AV block can occur without any preceding rhythm disturbances and is typically managed with permanent cardiac pacing to prevent recurrent syncope .
Complete heart block is a significant complication following congenital heart surgery. Factors such as preoperative digoxin exposure, aortic cross-clamp time, and specific genetic polymorphisms have been associated with an increased risk of postoperative AV block. Recovery of AV conduction post-surgery can be predicted by the presence of junctional acceleration and intermittent conduction during complete block.
Cardiac pacing is the primary treatment for symptomatic AV block. Advances in pacing technology, including leadless pacemakers and cardiac resynchronization therapy, have improved outcomes for patients with AV block. Pacing is indicated not only for symptomatic patients but also prophylactically in certain asymptomatic patients to prevent sudden death .
Animal models, such as the rat model of complete heart block, have been developed to study the pathophysiology and treatment of AV block. These models help in understanding the hemodynamic changes and myocardial damage associated with AV block, providing insights for future therapeutic interventions.
AV heart block encompasses a range of conditions with varying etiologies, clinical courses, and management strategies. Early diagnosis and appropriate intervention, particularly with cardiac pacing, are essential to prevent complications and improve patient outcomes. Ongoing research and advancements in pacing technology continue to enhance the management of this complex condition.
Most relevant research papers on this topic